Jami Maxson, MD
Family Medicine · Cedar Rapids, IANPI 1467504506
Payments from drug & device makers
Across 206 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$442
- AbbVie$405
- Amgen$331
- Novo Nordisk$300
- Mayne Pharma Commercial LLC$171
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$152
- plus $1K from 27 others
What the payments were for
- Food & beverage$3,197100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $442 |
| AbbVie(2 entities) | 32 | $405 |
| Amgen | 22 | $331 |
| Novo Nordisk | 20 | $300 |
| Mayne Pharma Commercial LLC | 1 | $171 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $152 |
| Boehringer Ingelheim | 10 | $146 |
| Pfizer | 9 | $137 |
| Lilly USA, LLC | 7 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $98 |
| GSK | 7 | $97 |
| Merck | 6 | $83 |
| Bayer | 5 | $76 |
| Bausch Health US, LLC | 4 | $66 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $65 |
| Biohaven Pharmaceuticals, Inc. | 4 | $57 |
| E.r. Squibb & Sons, L.L.C. | 1 | $54 |
| Kowa Pharmaceuticals America, Inc. | 3 | $49 |
| Amarin Pharma, Inc. | 3 | $48 |
| Johnson & Johnson | 3 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $41 |
| Dynavax Technologies Corporation | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $25 |
| Novartis | 2 | $25 |
| Myovant Sciences Inc. | 1 | $24 |
| Mylan Specialty L.p. | 1 | $18 |
| Genentech USA, Inc. | 1 | $17 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$3,204 in reported general payments places this provider in the 90th percentile of 1,357 family medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 25 | $609 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $501 |
| Levothyroxine Sodium | 36 | $301 |
| Atorvastatin Calcium | 46 | $228 |
| Pantoprazole Sodium | 16 | $163 |
| Omeprazole | 21 | $111 |
| Losartan Potassium | 23 | $105 |
| Amlodipine Besylate | 28 | $100 |
| Lisinopril | 20 | $81 |
| Trazodone Hcl | 14 | $75 |
| Escitalopram Oxalate | 12 | $29 |
| Hydrochlorothiazide | 16 | $16 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cedar Rapids
- Casey BoylesCedar Rapids$8K
- Ann SoenenCedar Rapids$8K
- Nicholas GoetschWaterloo$4.1M
- James PoockWaterloo$1.5M
- Jennifer KayCouncil Bluffs$613K
- Nicholas BechtoldSioux City$584K
- Kirk PetersonHuxley$576K
- Stephen HarrisonClinton$249K
- Sharon SteenBelle Plaine$241K
- Carlos Alarcon SchroderJohnston$237K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.